I call this meeting to order.
Welcome to meeting number 135 of the House of Commons Standing Committee on the Status of Women.
To all members, please wait until I recognize you by name prior to speaking, and I remind you that all comments should be addressed through the chair. Thank you in advance for your co-operation.
Pursuant to Standing Order 108(2) and the motions adopted by the committee on Tuesday, June 4, 2024, and Wednesday, September 25, 2024, the committee will resume its study of breast cancer screening for women aged 40.
At this point, I'd like to welcome our witnesses, who are all appearing by video conference this morning.
From the Canadian Indigenous Nurses Association, we have Dr. Angeline Letendre, vice-president. From Ontario Health, we have Alethea Kewayosh, director, indigenous cancer care unit and indigenous health equity and coordination; and Dr. Amanda Sheppard, senior scientist. From The Olive Branch of Hope Cancer Support Services, we have Dr. Juliet Daniel, professor. Finally, from the University of British Columbia, we have Dr. Nadine Caron, First Nations Health Authority chair in cancer and wellness.
I'd like to thank all of you for coming back for today's discussion so we can have additional commentary.
We will begin with opening statements.
Dr. Letendre, you have the floor for up to five minutes.